Dental Practice Broker or Sell-Side Advisor: Which Do You Need in 2026?

August 18, 2026

I want to answer this one honestly, including the part where the answer is “not us.”

For a lot of dental practices, a broker is the right call. For a smaller number, a structured competitive process is worth many times what it costs.

The difference is not about quality of service. It is about what kind of transaction your practice actually is.

Key takeaways

A broker matches. An advisor competes. One finds you a buyer. The other makes buyers bid against each other.
The dividing line is roughly the point where funded groups would compete for your practice. Below it, matching is efficient. Above it, matching leaves money behind.
Ask who pays your representative. If any part of the fee comes from the buyer side, the incentives are not fully yours.
A listing is not a process. Publishing a practice and waiting for enquiries produces a different outcome from running a private bid window among vetted buyers.
The cost of the wrong choice is asymmetric. Overpaying for representation costs a fee. Under-representing a valuable practice costs a multiple.

What is the difference between a dental practice broker and a sell-side advisor? A broker typically lists a practice and matches it to a buyer, often an individual dentist, earning a commission on the sale. A sell-side M&A advisor represents the seller exclusively, prepares the practice financially, and runs a competitive process among multiple vetted buyers to establish price through bidding.

What each one actually does

A practice broker lists your practice, markets it to their buyer network, and matches you with a purchaser. It is a transactional service and, for a straightforward owner-operated practice being sold to an individual dentist, an efficient one.

Brokers know their local market, they know which buyers are financeable, and matching is genuinely useful work.

A sell-side M&A advisor does something structurally different. The advisor prepares the practice before anyone sees it, identifies which organizations would realistically compete for it, and runs a controlled process in which those buyers bid against each other with knowledge that others are at the table.

The word that separates them is competition. A broker’s job is largely complete when a willing buyer is found.

An advisor’s job is largely about ensuring more than one willing buyer exists at the same moment.

The size question, answered plainly

The honest dividing line is not a revenue figure. It is a question: would more than one funded organization genuinely want this practice?

For a single-location practice at modest collections, heavily dependent on the owner’s own production, the realistic buyer is usually an individual dentist or a small local group. There is not much of a competitive dynamic to create.

A broker is the sensible route.

Once a practice reaches the size and profile where DSOs and partnership groups would each want it, the situation inverts. Now there are multiple genuinely interested, well-capitalized buyers, and the only question is whether they ever find out about each other.

A commonly cited threshold in the industry sits around $750,000 of adjusted EBITDA, or ownership of two or more locations. That is a reasonable rough marker, though profile matters as much as size.

An associate-led single location with strong hygiene can attract more competitive interest than a larger practice where the owner produces most of the dentistry.

The market context makes the point. There are roughly 130 private equity-backed DSOs in the US, the Association of Dental Support Organizations counts 80-plus member companies, and Becker’s tracked more than 200 DSO affiliations in 2025.

That is a deep buyer pool. For a practice that pool wants, selling to the first one who calls is leaving the pool unused.

Where the incentives sit

This is the question I would ask first if I were an owner, and almost nobody does.

Who pays your representative, and does any portion of their compensation come from the buyer’s side?

Some intermediaries in healthcare transactions receive fees from buyers, or maintain ongoing relationships with a small set of acquirers who provide repeat volume. That does not make them dishonest.

It does mean their interests are not purely aligned with getting you the highest number from the widest field.

A sell-side advisor representing you exclusively takes no fee from any buyer. Every dollar of their compensation depends on your outcome.

Ask directly. A straight answer is a good sign either way.

What a real process looks like

A structured sale is not a listing with more marketing. The sequence matters.

Preparation first. Before any buyer sees a number, the financials get normalized and stress-tested. When we prepare a practice, part of the work is a thorough pre-sale financial review on our side of the table, built around exactly the scrutiny the buyers’ accountants will apply.

That gives months to correct anything that would not survive a deep audit. An EBITDA figure that gets picked apart during diligence turns into a re-trade, and a re-trade after you have gone exclusive with one buyer is the weakest position in the whole transaction.

Then buyer selection. Not everyone who would like to bid should be allowed to. This is what the Elite Selling System is built around: we hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.

Then the bid window. Buyers submit knowing others are submitting. This is where price discovery actually happens.

Then terms, not just price. Cash at close versus rollover equity and earnout. How long you stay and on what hours.

What happens to your team. Whether the earnout targets are reachable.

In my experience these are where competition pays off most, and they are almost entirely non-negotiable when only one buyer is present.

Then confidentiality throughout. Your staff, patients and referral sources learn nothing until you decide otherwise. A publicly listed practice cannot offer that.

The same practice, both routes

Numbers make this concrete, so here is the comparison as it usually plays out.

A practice with $700,000 of adjusted EBITDA. Two doctors, decent hygiene, one location.

Route one, the direct offer. A group approaches the owner. They negotiate reasonably, the owner pushes back once, and the deal lands at 6x.

That is $4.2 million. No advisory fee.

The owner keeps every dollar.

Route two, the competitive process. Five vetted buyers are approached under confidentiality. Three bid.

The winning bid comes in at 7.5x, or $5.25 million, and it arrives with more cash at close and a shorter required stay, because the buyer was competing on terms as well as price.

The difference is $1,050,000 before any fee.

Subtract the cost of representation, whatever it is on a practice that size, and the owner is still ahead by a wide margin. That is the arithmetic.

It is also why the fee question is the wrong first question.

But notice what had to be true. Three buyers had to genuinely want it.

Had only one bidder shown up, the process would have cost money and produced nothing better than route one.

Which is exactly why I keep returning to the same test. When several funded buyers would compete for your practice, the case is overwhelming.

When they would not, paying for a process is paying for machinery with nothing to run on.

The uncomfortable question about fees

Advisory representation costs more than a brokerage commission. That is a real consideration and worth being direct about.

Our fee varies depending on the value of the practice, and it is entirely success-based. If we do not get you a result, we do not get paid.

The way to evaluate that is not the fee in isolation. It is the fee against the spread between a direct, uncontested offer and a competitive outcome on the same practice.

On a practice of meaningful size, a single additional multiplier point typically exceeds the entire cost of representation, several times over.

But that logic only holds if your practice is one that multiple funded buyers would actually compete for. If it is not, you are paying for a process that has nothing to work with, and a broker is the better answer.

We will tell you if that is the case.

What preparation actually adds

The part that gets least attention in this comparison is the work that happens before anyone markets anything, and it is where a lot of the difference is made.

A practice that goes to market with normalized, defensible financials attracts better bids and holds them. One that goes to market with financials nobody has stress-tested attracts bids that get revised downward during diligence, which is the same as not having received them.

I mentioned the re-trade earlier. Here is what it costs in numbers.

On a practice being priced at 8x, $150,000 of add-backs that cannot be evidenced is not a $150,000 problem. It is a $1.2 million problem, because the disallowed earnings get multiplied like everything else.

Preparation is not paperwork. It is the highest-leverage financial work available to an owner in the year before a sale.

Dental practice financial records on a desk

What neither route can do for you

Worth saying plainly, because both brokers and advisors occasionally imply otherwise.

Nobody can make a practice worth more than its earnings and its risk profile support. What the practice is worth is set by adjusted EBITDA and the multiple it commands.

A structured process finds the top of your range. It does not invent a range you were never in.

If your production runs entirely through your own hands, if hygiene is thin, if overhead sits well above benchmark, those are facts about the practice. A competitive process gets you the best available price for that practice.

It does not turn it into a different one.

Which is the honest reason preparation and process belong together. The preparation raises the range.

The process finds the top of it. Doing one without the other leaves money in a predictable place.

How to decide

Ask yourself three questions.

Would more than one funded organization want this practice? If plainly yes, a competitive process is worth it. If plainly no, it is not.

How much of the value is in the terms rather than the headline? If your post-sale role, your hours, your team’s future or the structure of the payout matter to you, those are negotiated far better with competitive pressure.

How prepared are the financials? If your EBITDA would not survive a buyer’s accountants going through it line by line, the preparation work is worth more than the process itself, and it needs to happen first regardless of who represents you.

If you want a straight read on which side of that line you fall, we will give you one.

That starts with a free, confidential practice value estimate, and it includes an honest answer when the honest answer is that you do not need us.

The case for doing nothing yet

Worth including, because it is sometimes the right answer and neither a broker nor an advisor has much incentive to say it.

If your financials would not survive a buyer’s accountants going through them line by line, hiring anyone right now is premature. That preparation window is most of how long the whole process takes.

The preparation work has to happen regardless of who eventually represents you, and doing it first means you go to market from a stronger position with a higher range.

If your production runs almost entirely through your own hands, you are in the same situation. Shifting even part of it to an associate over eighteen months changes both what the practice earns and what a buyer will pay for it.

And if you are more than five years from wanting to stop, there is no urgency at all. Get a valuation so you know where you stand, fix the two things it identifies, and revisit.

The only genuinely bad option is drifting: neither preparing nor selling, while the years that would have made the difference go past.

Three questions that reveal more than any pitch

If you are interviewing either a broker or an advisor, these three surface the differences quickly.

“How many buyers would you put in front of this practice, and who are they?” A specific answer with named categories is a good sign. A vague answer about an extensive network is not.

Anyone who genuinely knows your market can tell you which regional groups already operate near you.

“What happens between signing with you and the first buyer seeing my numbers?” If the answer is short, there is no preparation phase. That is the phase that protects your price during diligence, and its absence is the single best predictor of a re-trade later.

“Who pays you, and does any part of your compensation come from the buyer’s side?” Asked directly, this gets an honest answer nearly every time. Either answer can be workable.

Not knowing is what costs you.

Notice that none of those are about fees. Fee level is the easiest thing to compare and the least informative.

Two representatives charging identically can produce outcomes that differ by seven figures on the same practice, and the difference will be in the answers to the three questions above.

Frequently asked questions

What is the difference between a dental practice broker and an M&A advisor?

A broker lists and markets a practice and matches it to a buyer, typically earning a commission. A sell-side M&A advisor represents the seller exclusively, prepares the practice financially, and runs a structured competitive process among multiple vetted buyers so price is established by bidding.

At what size should I use an advisor instead of a broker?

The practical marker is whether multiple funded organizations would genuinely compete for your practice. A commonly cited threshold is around $750,000 of adjusted EBITDA or two or more locations, though profile matters as much as size.

Do I need anyone at all if a DSO has already made me an offer?

An existing offer is a reason to get representation, not a reason to skip it. A single offer has no benchmark.

The value of representation at that point is establishing what other qualified buyers would pay for the same practice.

How much does a sell-side advisor cost?

Fees vary depending on the value of the practice and are typically success-based, meaning no result means no fee. The relevant comparison is not the fee alone but the fee against the difference between an uncontested offer and a competitive outcome.

Can my attorney or CPA handle the sale instead?

Both are essential, and neither substitutes for the other function. Your attorney negotiates and papers the agreement.

Your CPA handles tax structure. Neither typically creates competition among buyers, which is where most of the price difference is made.

Is a listed practice the same as a marketed one?

No. A public listing announces that your practice is for sale, which carries confidentiality risk with staff, patients and referral sources.

A private process approaches a selected set of vetted buyers under confidentiality obligations.

What should I ask any representative before hiring them?

Ask who pays them and whether any portion of their compensation comes from the buyer’s side. Ask how many buyers they would put in the process and how those buyers are selected.

Ask what preparation work happens before any buyer sees the financials.

Sources

Transaction process and legal

Mandelbaum Barrett PC. “The Four-Phase DSO Transaction Process: What to Expect When Selling a Dental Practice.” mblawfirm.com
Cranfill Sumner LLP. “Selling Your Dental Practice to a DSO: What to Expect Before, During, and After the Deal.” cshlaw.com
Benesch. “Dental/DSO Industry Newsletter, May/June 2026.” beneschlaw.com
Congressional Research Service. “Private Equity Investments in Health Care: Selected Enforcement Issues.” congress.gov
US House Committee on Oversight. “Survey of State Laws Governing the Corporate Practice of Dentistry.” oversight.house.gov

Buyer pool and market activity

Association of Dental Support Organizations. “About ADSO.” theadso.org
Becker’s Dental Review. “200+ DSO affiliations in 2025: State-by-state breakdown.” beckersdental.com
Becker’s Dental Review. “69% of DSOs plan to boost acquisitions in 2026: Report.” beckersdental.com
Becker’s Dental Review. “The largest DSOs headed into 2026.” beckersdental.com
Becker’s Dental Review. “52 DSOs to know: 2026.” beckersdental.com
Group Dentistry Now. “DSO Deal Roundup — July 2026.” groupdentistrynow.com

Ownership and workforce context

ADA Health Policy Institute. “Practice Ownership Trends in Dentistry.” ada.org
ADA News. “More dentists affiliating with DSOs.” adanews.ada.org
ADA Health Policy Institute. “Dental Practice Research.” ada.org
ADA Health Policy Institute. “The State of the U.S. Dental Economy, Q1 2026 Update.” ada.org